Ambiq CTO granted 80,308 RSUs in Form 4
Hanson Scott McLean reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hanson Scott McLean reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. director and Chief Technology Officer Scott McLean received a grant of 80,308 restricted stock units of Common Stock as equity compensation. These RSUs vest over time, with 25% vesting on September 1, 2027 and the remainder vesting quarterly thereafter, contingent on continued service. Following this award, McLean directly holds 203,126 shares of Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 80,308 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents the grant of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 25% of the shares subject to the RSU will vest on September 1, 2027, and 1/12 of the shares subject to the RSU will vest quarterly thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan).
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ambiq Micro (AMBQ) report for Scott McLean?
Is the Ambiq Micro (AMBQ) Form 4 transaction a stock purchase or a compensation grant?
How do Scott McLean’s Ambiq Micro (AMBQ) RSUs vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.